Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06444854
Other study ID # PROTECTR
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date July 1, 2024
Est. completion date December 31, 2026

Study information

Verified date May 2024
Source Lawson Health Research Institute
Contact Deb Lewis
Phone 5196858500
Email deb.lewis@lhsc.on.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is a single centre, prospective clinical trial evaluating the safety and feasibility of implementing a same day chest tube removal protocol in patients undergoing Video Assisted Thoracic Surgery (VATS) anatomical pulmonary surgery.


Description:

Pulmonary resections are performed for a multitude of diagnostic and therapeutic reasons. The last decade has seen a rapid advancement of minimally invasive surgical (MI) approaches which have resulted in improved patient outcomes. However, the post-operative care pathways have not evolved sufficiently to account for these changes. As such, many patients are still admitted after a minor lung resection for monitoring with a chest tube remaining in situ for a minimum of 24 hours. There have been a few retrospective cohort studies that demonstrate that patients do not experience significant complications during that 24-hour period that would warrant hospitalization. However, there have been no prospective controlled studies evaluating the safety and feasibility of early chest tube removal and discharge after a wedge resection. Furthermore, the maintenance of a large bore chest tube for an extended period is a cause for increased patient discomfort, increased narcotic use and may contribute to chronic pain secondary to intercostal nerve compression. As such, the prolonged chest tube maintenance and hospitalization may overall result in more patient harm than benefit. Our group recently completed and presented a prospective safety and feasibility study demonstrating that chest tubes can be discontinued as early as 3 hours after minor MIS wedge resections of the lung with no adverse events. This study validated safety criteria that will be implemented moving forward. Furthermore, the maintenance of a large bore chest tube for an extended period is a cause for increased patient discomfort, increased narcotic use and may contribute to chronic pain secondary to intercostal nerve compression. As such, the prolonged chest tube maintenance and hospitalization may overall result in more patient harm than benefit. In the study mentioned previously, early chest tube removal led to 40% more patients being opioid free at post operative day 1 compared to those who underwent routine care. Nevertheless, it is unclear if patients who undergo more extensive surgeries involving vascular dissection and longer operative times (i.e., pulmonary lobectomies and segmentectomies) will derive the same benefit. The incisions required to complete more complex operations are also larger compared to wedge resections. As such the pain associated with having a chest tube may or may not be as apparent in the setting of the larger incision. It is also unclear what the long-term impact of early chest tube removal has on quality of life in the perioperative period.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 130
Est. completion date December 31, 2026
Est. primary completion date July 1, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - 18 yrs or older - scheduled to undergo elective VATS segmental or lobar resection of the lung Exclusion Criteria: - Pulmonary function tests demonstrating forced expiratory volume in 1 second (FEV1) <50% predicted, FEV1 <1.5L and/or diffusion lung capacity of carbon monoxide (DLCO) <50% predicted - Patient receives an intraoperative pleurodesis - Conversion to open thoracotomy or mini thoracotomy intraoperatively. - Underlying cognitive disorder resulting in inability to complete activities of daily living.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
early chest tube removal
Chest tube removal

Locations

Country Name City State
Canada London Health Sciences Centre London Ontario

Sponsors (1)

Lead Sponsor Collaborator
Lawson Health Research Institute

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of successful same day chest tube removal These patients have chest tube removed if they meet study criteria 30 days post-op
Primary EQ5D5L score Difference in EQ5D5L scores between standard care and early chest tube removal on POD1 and POD30. 30 days post-op
Primary MME POD1 Mean Morphine Equivalents used on post operative day 1 24 hours
Primary Pleural reintervention Rate of pleural reintervention (defined as requiring reinsertion of a chest tube or return to the operating room) 30 days post-op
Secondary Complications The rates of grade 1 to 5 complications as per the TSQIC will be recorded for up to 30 days after surgery in the divisional thoracic REDCap database. 30 days post-op
Secondary Chest Tube duration Duration the patient had chest tubes in situ will be measured by collecting the date and time of arrival to PACU and the date and time the chest tube was removed. 30 days post-op
Secondary Unplanned return Unplanned returns to clinic or emergency room within the first 30 days after surgery 30 days post-op
Secondary LOS Duration of hospital length of stay 30 days post-op
See also
  Status Clinical Trial Phase
Recruiting NCT04451473 - Lung Surgery With Enhanced Recovery VS. Lung Surgery Without Enhanced Recovery N/A
Recruiting NCT04909567 - Optimization of Patients' Physical and Mental Status Prior to Colorectal Cancer Surgery N/A
Recruiting NCT06103526 - Immunonutrition in ERAS Protocols in Gynecologic Oncology N/A
Completed NCT04586257 - Effect of Regional Anesthesia on Enhanced Recovery After Spine Surgeries N/A
Active, not recruiting NCT06088082 - "Analgesic Efficacy of Combined Transversus Abdominis Plane Block and Posterior Rectus Sheath Block in Patients Undergoing Laparoscopic Appendectomy" Phase 3
Completed NCT04645654 - Brief Postoperative Hypnosis Intervention as Multimodal Analgesia After Major Abdominal Surgery N/A
Completed NCT04438590 - Kelulut Honey as an Alternate Source of Carbo-Loading in Abdominal Surgery Involving the Digestive System N/A
Completed NCT04873544 - Enhanced Recovery After Surgery Protocols in Total Knee Arthroplasty Via Midvastus Approach N/A
Recruiting NCT05617768 - Enhanced Recovery After Surgery (ERAS)Guidelines in Mitral Valve Surgeries, Questionnaire
Not yet recruiting NCT06066190 - Web-Based Education on ERAS Protocols Applied in Gynecological and Obstetric Surgery N/A
Completed NCT05665712 - Pediatric Enhanced Recovery After Cardiac Surgery
Recruiting NCT05962684 - A Greek-designed ERAS Protocol in Elective Craniotomy
Recruiting NCT05738902 - Adherence and Compliance to ERAS in Gynecological Surgery
Not yet recruiting NCT06424938 - Postoperative Analgesia in Major Gynecological Cancer Surgeries N/A
Recruiting NCT05231473 - Impact Of The Nurse Enhanced Recovery After Surgery Coordinator On The Compliance In Colorectal Surgery (nursERAS-BCN) N/A
Enrolling by invitation NCT04964856 - Enhanced Recovery After Surgery Exercise Improve Perioperative Frailty N/A
Completed NCT05033899 - Enhanced Recovery After Spinal Surgery Protocol Versus Conventional Care in Non Insulin Diabetic Patients ( ERAS ) N/A
Completed NCT04870242 - Studding the Implementation of ERAS Protocols in Pediatric Surgery
Recruiting NCT03949114 - Rehabilitation Intervention on Prevention of Postoperative Delirium N/A
Recruiting NCT06050551 - Pigtail or Chest Tube Placement After Uniportal Video-assisted Thoracoscopic Surgery N/A